A multicentered randomized phase II comparison of single-agent carboplatin versus the combination of carboplatin and everolimus for the treatment of advanced triple-negative breast cancer.

被引：0

作者：

Fukui, Jami Aya

Shapiro, Charles L.

Ru, Meng

Klein, Paula

Fasano, Julie

Bhardwaj, Aarti

Irie, Hanna

Mandeli, John P.

Goel, Anupama

Kumarley, Neha

Gomes, Joni

Shuman, Nicholas

Francois, Damien

Tiersten, Amy

机构：

[1] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA

[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[3] Mt Sinai Chelsea, New York, NY USA

[4] NYU, Med Ctr, New York, NY 10016 USA

[5] Mt Sinai Hosp, New York, NY 10029 USA

[6] Mt Sinai Sch Med, New York, NY USA

[7] Mt Sinai West, New York, NY USA

[8] Tisch Canc Inst, New York, NY USA

[9] Mt Sinai Hlth Syst, New York, NY USA

[10] Beth Israel Deaconess Med Ctr, Continuum Canc Ctr New York, New York, NY 10003 USA

来源：

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.TPS1109

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS1109

引用

页数：1